School of Medicine

ReissCraig Reiss has been named the Sam and Marilyn Fox Distinguished Professor in Medicine at the School of Medicine. Reiss, a cardiologist, directs the Washington University Cardiology Consultants and the Heart Care Institute at Barnes-Jewish West County Hospital.

Current medications for seizures are comparable to over-the-counter cold and flu remedies: They block symptoms, but don’t significantly affect the underlying illnesses that cause them. Now scientists at the School of Medicine have taken the first step toward developing another option. They’ve used a drug to prevent the brain abnormalities that lead to seizures in mice with an inherited form of epilepsy.

Nanoparticles (yellow) show that a treated tumor (left) has less blood vessel growth than an untreated tumor.Anyone facing chemotherapy would welcome an advance promising to dramatically reduce their dose of these often harsh drugs. Using nanotechnology, researchers at the School of Medicine have taken a step closer to that goal. The researchers focused a powerful drug directly on tumors in rabbits using drug-coated nanoparticles.

Photo by Robert BostonGraduating medical students learn where they will do their residencies at Match Day March 20 in Moore Auditorium.

School of Medicine researchers found that depressed heart attack patients have a higher risk for sudden death for years following a heart attack.

The recently established Institute of Clinical and Translational Sciences (ICTS) has awarded its first set of grants to 15 ICTS investigators.

Fifteen projects from a wide range of fields received more than $800,000 in research funds.

The School of Medicine has received a five-year, $3.9 million grant to lead research to improve outcomes for children undergoing lung transplants.

Below is a link to the Washington University news release about the U.S. News & World Report undergraduate rankings for 2004-05: http://news-info.wustl.edu/news/page/normal/3627.html To view a full listing of U.S. News magazine, book and Web-only rankings for 2004-05, please visit the U.S. News & World Report site: http://www.usnews.com/usnews/edu/college/rankings/rankindex_brief.php

School of Medicine research suggests that inactivating platelets could slow down or prevent metastasis of cancer. Scientists report that a combination of two platelet inhibitors reduced the number and size of breast cancer or melanoma tumors that grew in the bones of laboratory mice.